Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 296,697 | 1,313,149 | 919,715 | 574,064 | 264,431 |
| Depreciation Amortization | 181,783 | 717,322 | 536,651 | 356,813 | 175,854 |
| Income taxes - deferred | -12,723 | -45,452 | -103,203 | -72,560 | -52,797 |
| Accounts receivable | -265,008 | -331,260 | -242,093 | -142,494 | -93,507 |
| Accounts payable and accrued liabilities | 76,990 | 27,208 | 70,428 | 48,724 | 12,411 |
| Other Working Capital | -277,921 | -17,201 | 68,558 | -24,213 | 58,058 |
| Other Operating Activity | 179,983 | 296,281 | 161,668 | 92,116 | 82,820 |
| Operating Cash Flow | $179,801 | $1,960,047 | $1,411,724 | $832,450 | $447,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -246,258 | -935,535 | -636,183 | -411,437 | -197,617 |
| Net Acquisitions | -90,842 | -65,150 | -123,181 | -66,159 | -11,218 |
| Investing Cash Flow | $-337,100 | $-1,000,685 | $-759,364 | $-477,596 | $-208,835 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 328,156 | 346,330 | 270,090 | 165,826 | 73,761 |
| Debt Issued | 60 | 6,035 | 5,972 | 4,191 | 1,860 |
| Debt Repayment | -53,495 | -324,855 | -264,693 | -138,625 | -60,850 |
| Common Stock Issued | 2,544 | 94,166 | 67,234 | 53,762 | 16,451 |
| Dividend Paid | N/A | -263,244 | -263,244 | -263,244 | N/A |
| Other Financing Activity | -162,318 | -865,971 | -449,630 | -215,686 | -268,511 |
| Financing Cash Flow | $114,947 | $-1,007,539 | $-634,271 | $-393,776 | $-237,289 |
| Exchange Rate Effect | 10,622 | -36,178 | -30,567 | -12,774 | -12,079 |
| Beginning Cash Position | 549,500 | 633,855 | 633,855 | 633,855 | 633,855 |
| End Cash Position | 517,770 | 549,500 | 621,377 | 582,159 | 622,922 |
| Net Cash Flow | $-31,730 | $-84,355 | $-12,478 | $-51,696 | $-10,933 |
| Free Cash Flow | |||||
| Operating Cash Flow | 179,801 | 1,960,047 | 1,411,724 | 832,450 | 447,270 |
| Capital Expenditure | -250,178 | -952,943 | -647,350 | -417,751 | -201,196 |
| Free Cash Flow | -70,377 | 1,007,104 | 764,374 | 414,699 | 246,074 |